Stage IV Adult Diffuse Large Cell Lymphoma Completed Phase 1 Trials for Vorinostat (DB02546)

IndicationStatusPhase
DBCOND0028711 (Stage IV Adult Diffuse Large Cell Lymphoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00275080Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous LeukemiaTreatment
NCT00499811Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver DysfunctionTreatment